The first thing to remember is that everybody with a diagnosis of scleroderma is at risk of developing lung disease — either interstitial lung disease (ILD), which affects about 60 […]
For too long, doctors treating rheumatic diseases have had to base their management on instinct and experience.
The problem is that each physician has a limited experience – which means that many times we basically had to guess at how to treat a specific patient, using trial and error to find out what might work best.
This issue of Leap, although autoimmunity is on the cover, is actually about the many points of connection here in the Division of Rheumatology. First, of course, is our connection to our patients. It’s not just physicians, nurses, and staff. It’s also our scientists, working to discover how these diseases start and how they might be stopped.
Please see the first issue of LEAP – a hot off the press magazine about the Division of Rheumatology at Johns Hopkins. In these pages you will learn more about who we are and what we’re all about. Enclosed are stories and images about the talented staff, postdoctoral fellows and faculty who make up our team.